Enlaza: Enlaza: Creating covalent biologics using engineered amino acids

APR 30, 2024 | 4:56 AM PDT | BIOCENTURY | EMERGING COMPANY PROFILEENLAZA: CREATING COVALENT BIOLOGICS USING ENGINEERED AMINO ACIDSBY Avalon-incubated biotech now has $161M to advance what could be the first covalent, irreversible protein drugs, starting in oncologyhttps://www.biocentury.com/article/652257/enlaza-creating-covalent-biologics-using-engineered-amino-acids© 2024 BioCentury Inc. All Rights Reserved